Welcome to Markets Desk, here's what's moving the needle this afternoon.
Amgen is reporting a significant clinical breakthrough, with its experimental drug combination cutting the risk of death by fifty-eight percent in patients with aggressive lung cancer when paired with AstraZeneca's immunotherapy. That's a result that will draw serious attention from oncology investors and could reshape the competitive landscape in cancer treatment.
Shifting to crypto infrastructure, Bitcoin Core has amended its security policy to accelerate the backporting of vulnerability fixes across all maintained release lines. The urgency is real — a network snapshot from earlier this month shows that nearly forty-four percent of surveyed nodes are running end-of-life software, leaving a substantial portion of the Bitcoin network exposed to known and potentially rediscoverable threats.
And on the consumer side, Costco is quietly becoming a force in the travel business. The warehouse giant sent more than seven hundred fifty thousand members on cruises during fiscal two thousand twenty six, a sixteen percent jump year over year. As Costco continues expanding its travel offerings, it's another signal that the company's membership model has pricing power well beyond the warehouse floor.
That's the tape. Markets Desk, signing off the floor.
